2026 · 2nd Quarter (Apr 1 - June 30)

AMERICAN ASSOCIATION FOR CANCER RESEARCH

Filed by AMERICAN ASSOCIATION FOR CANCER RESEARCH.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 17, 2026
Income: Not reported
Expenses: $100,000.00
Registrant: AMERICAN ASSOCIATION FOR CANCER RESEARCH
Client: AMERICAN ASSOCIATION FOR CANCER RESEARCH
Filing UUID: dad62269-a548-4cb8-8613-c8738458c323
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

MED · Medical/Disease Research/Clinical Labs

Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

TOB · Tobacco

Tobacco control and prevention Tobacco cessation

HCR · Health Issues

Reducing cancer disparities Cancer survivorship

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.